4 Gy versus 24 Gy radiotherapy for follicular and marginal zone lymphoma (FoRT): long-term follow-up of a multicentre, randomised, phase 3, non-inferiority trial

Hoskin, Peter; Popova, Biliana; Schofield, Oliver; Brammer, Caroline; Robinson, Martin; Brunt, Adrian Murray; Madhavan, Krishnaswamy; Illidge, Tim; Gallop-Evans, Eve; Syndikus, Isabel; Clifton-Hadley, Laura; Kirkwood, Amy A.

doi:10.1016/S1470-2045(20)30686-0

All Outputs (2)

Moving Forward Fast with FAST-Forward (2021)
Journal Article
Lewis, P., Brunt, A., Coles, C., Griffin, S., Locke, I., & Roques, T. (2021). Moving Forward Fast with FAST-Forward. Clinical Oncology, 33(7), 427-429. https://doi.org/10.1016/j.clon.2021.04.007

4 Gy versus 24 Gy radiotherapy for follicular and marginal zone lymphoma (FoRT): long-term follow-up of a multicentre, randomised, phase 3, non-inferiority trial (2021)
Journal Article
Hoskin, P., Popova, B., Schofield, O., Brammer, C., Robinson, M., Brunt, A. M., …Kirkwood, A. A. (2021). 4 Gy versus 24 Gy radiotherapy for follicular and marginal zone lymphoma (FoRT): long-term follow-up of a multicentre, randomised, phase 3, non-inferiority trial. Lancet Oncology, 22(3), 332-340. https://doi.org/10.1016/S1470-2045%2820%2930686-0

BACKGROUND: The optimal radiotherapy dose for indolent non-Hodgkin lymphoma is uncertain. We aimed to compare 24 Gy in 12 fractions (representing the standard of care) with 4 Gy in two fractions (low-dose radiation). METHODS: FoRT (Follicular Radioth... Read More about 4 Gy versus 24 Gy radiotherapy for follicular and marginal zone lymphoma (FoRT): long-term follow-up of a multicentre, randomised, phase 3, non-inferiority trial.